Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20091
20102
20112
20121
20133
20142
20151
20171
20182
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
University College, London3
Amgen Research (Munich) GmbH2
Kiadis Pharma2
University of Birmingham2
Amgen1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Genzyme, a Sanofi Company1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma22
Leukemia, Myeloid, Acute10
Myelodysplastic Syndromes7
Leukemia6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Hodgkin Disease4
Lymphoma, Non-Hodgkin4
Graft vs Host Disease3
Hematologic Neoplasms3
Neoplasms3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.